
Number of publications published per year by Wallace, Karen. (Source : PubMed)

Distribution of publications types for Wallace, Karen. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.
Toxicology
2010;268;1-2

The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.
Cancer Epidemiol. Biomarkers Prev.
2009;18;8

Interleukin-1 participates in the progression from liver injury to fibrosis.
Am. J. Physiol. Gastrointest. Liver Physiol.
2009;296;6



Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.
Cancer Epidemiol. Biomarkers Prev.
2009;18;4
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.
Comp Hepatol
2009;8


Selenium and risk of bladder cancer: a population-based case-control study.
Cancer Prev Res (Phila Pa)
2009;2;1
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.
Hepatology international
2008;2;4

Evidence against the nuclear in situ binding of arsenicals--oxidative stress theory of arsenic carcinogenesis.
Toxicol. Appl. Pharmacol.
2008;232;2


MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
Cancer Epidemiol. Biomarkers Prev.
2008;17;9
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
J. Hepatol.
2008;49;1
[ See timeline ] [ See all publications ]
means that Wallace, Karen has 29 papers cited a least 29 times - methodology
Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hamsphire, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.